Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EchoIQ Limited ( (AU:EIQ) ) has shared an update.
Echo IQ Limited has issued 1,625,000 fully paid ordinary shares following the exercise of vested performance rights, expanding its quoted share capital on the Australian Securities Exchange. The company advised that the shares were issued without a prospectus under relevant Corporations Act provisions and confirmed it is compliant with its financial reporting and continuous disclosure obligations, with no excluded information currently withheld from the market.
The most recent analyst rating on (AU:EIQ) stock is a Hold with a A$0.90 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
Echo IQ Limited is an Australian AI and medical technology company based in Sydney that uses AI-driven technology and proprietary software to improve decision-making in cardiology. The company focuses on enhancing clinical assessment in heart care through advanced data analysis tools tailored to cardiologists and healthcare providers.
Average Trading Volume: 3,227,255
Technical Sentiment Signal: Buy
Current Market Cap: A$593.3M
For an in-depth examination of EIQ stock, go to TipRanks’ Overview page.